-
1
-
-
79955846044
-
OARSI/FDA Osteoarthritis Biomarkers Working group. Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis
-
Kraus V., Burnette B., Coindreau J., Cottrell S., Eyre D., Gendreau M., et al. OARSI/FDA Osteoarthritis Biomarkers Working group. Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cart 2011, 19:515-542.
-
(2011)
Osteoarthritis Cart
, vol.19
, pp. 515-542
-
-
Kraus, V.1
Burnette, B.2
Coindreau, J.3
Cottrell, S.4
Eyre, D.5
Gendreau, M.6
-
2
-
-
79955843724
-
Discovery and biochemical characterisation of four novel biomarkers for osteoarthritis
-
De Seny D., Sharif M., Fillet M., Cobraiville G., Meuwis M.-A., marée R., et al. Discovery and biochemical characterisation of four novel biomarkers for osteoarthritis. Ann Rheum Dis 2011, 70:1144-1152.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 1144-1152
-
-
De Seny, D.1
Sharif, M.2
Fillet, M.3
Cobraiville, G.4
Meuwis, M.-A.5
marée, R.6
-
3
-
-
84857138942
-
Fibulin-3 fragments (Fib3-1 and Fib3-2) are potential new biomarkers for the diagnosis of osteoarthritis
-
Henrotin Y., Gharbi M., Deberg M., Dubuc J.E., De Pauw E. Fibulin-3 fragments (Fib3-1 and Fib3-2) are potential new biomarkers for the diagnosis of osteoarthritis. Osteoarthritis Cart 2011, 19(Suppl 1):S79.
-
(2011)
Osteoarthritis Cart
, vol.19
, Issue.SUPPL. 1
-
-
Henrotin, Y.1
Gharbi, M.2
Deberg, M.3
Dubuc, J.E.4
De Pauw, E.5
-
4
-
-
33645047392
-
Fibulins 3 and 5 antagonize tumor angiogenesis in vivo
-
Albig A.R., Neil J.R., Schiemann W.P. Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res 2006, 66:2621-2629.
-
(2006)
Cancer Res
, vol.66
, pp. 2621-2629
-
-
Albig, A.R.1
Neil, J.R.2
Schiemann, W.P.3
-
5
-
-
0042698609
-
Cloning, expression and characterization of the murine Efemp1, a gene mutated in Doyne-Honeycomb retinal dystrophy
-
Ehlermann J., Weber S., Pfisterer P., Schorle H. Cloning, expression and characterization of the murine Efemp1, a gene mutated in Doyne-Honeycomb retinal dystrophy. Gene Expr Patterns 2003, 3:441-447.
-
(2003)
Gene Expr Patterns
, vol.3
, pp. 441-447
-
-
Ehlermann, J.1
Weber, S.2
Pfisterer, P.3
Schorle, H.4
-
6
-
-
3142714511
-
Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1). Implications for macular degenerations
-
Klenotic P.A., Munier F.L., Marmorstein L.Y., Anand-Apte B. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1). Implications for macular degenerations. J Biol Chem 2004, 279:30469-30473.
-
(2004)
J Biol Chem
, vol.279
, pp. 30469-30473
-
-
Klenotic, P.A.1
Munier, F.L.2
Marmorstein, L.Y.3
Anand-Apte, B.4
-
7
-
-
33947175117
-
Increased collagen and aggrecan degradation with age in the joints of Timp3(-/-) mice
-
Sahebjam S., Khokha R., Mort J.S. Increased collagen and aggrecan degradation with age in the joints of Timp3(-/-) mice. Arthritis Rheum 2007, 56:905-909.
-
(2007)
Arthritis Rheum
, vol.56
, pp. 905-909
-
-
Sahebjam, S.1
Khokha, R.2
Mort, J.S.3
-
8
-
-
9144230209
-
Expression profiling of metalloproteinases and their inhibitors in cartilage
-
Kevorkian L., Young D.A., Darrah C., Donell S.T., Shepstone L., Porter S., et al. Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 2004, 50:131-141.
-
(2004)
Arthritis Rheum
, vol.50
, pp. 131-141
-
-
Kevorkian, L.1
Young, D.A.2
Darrah, C.3
Donell, S.T.4
Shepstone, L.5
Porter, S.6
-
9
-
-
72949122333
-
Fibulin-3 negatively regulates chondrocyte differentiation
-
Wakabayashi T., Matsumine A., Nakazora S., Hasegawa M., Iino T., Ota H., et al. Fibulin-3 negatively regulates chondrocyte differentiation. Biochem Biophys Res Commun 2010, 391:1116-1121.
-
(2010)
Biochem Biophys Res Commun
, vol.391
, pp. 1116-1121
-
-
Wakabayashi, T.1
Matsumine, A.2
Nakazora, S.3
Hasegawa, M.4
Iino, T.5
Ota, H.6
-
10
-
-
79551658047
-
Proteomic analysis of articular cartilage vesicles from normal and osteoarthritis cartilage
-
Rosenthal A.K., Gohr C.M., Nimomiya J., Wakim T. Proteomic analysis of articular cartilage vesicles from normal and osteoarthritis cartilage. Arthritis Rheum 2011, 63:401-411.
-
(2011)
Arthritis Rheum
, vol.63
, pp. 401-411
-
-
Rosenthal, A.K.1
Gohr, C.M.2
Nimomiya, J.3
Wakim, T.4
-
11
-
-
79952766936
-
Enzyme-linked immunosorbent assay (ELISAs) for metalloproteinase derived type II collagen neoepitope, CIIM - Increased serum CIIM in subjects with severe radiographic osteoarthritis
-
Bay-Jensen A.C., Liu Q.J., Byrjalsen I., Li Y., Wang J., Pedersen C., Leeming D.J., et al. Enzyme-linked immunosorbent assay (ELISAs) for metalloproteinase derived type II collagen neoepitope, CIIM - Increased serum CIIM in subjects with severe radiographic osteoarthritis. Clin Biochem 2011, 44:423-429.
-
(2011)
Clin Biochem
, vol.44
, pp. 423-429
-
-
Bay-Jensen, A.C.1
Liu, Q.J.2
Byrjalsen, I.3
Li, Y.4
Wang, J.5
Pedersen, C.6
Leeming, D.J.7
-
12
-
-
84857143016
-
A unique deamidated cartilage oligomeric matrix protein (COMP) biomarker preferentially identifies hip osteoarthritis
-
S72(142)
-
Catterall J., Hsueh M.-F., Stabler T.V., Renner J.M., Jordan J.M., Kraus V.B. A unique deamidated cartilage oligomeric matrix protein (COMP) biomarker preferentially identifies hip osteoarthritis. Osteoarthritis Cart 2011, 19(Suppl 1). S72(142).
-
(2011)
Osteoarthritis Cart
, vol.19
, Issue.SUPPL. 1
-
-
Catterall, J.1
Hsueh, M.-F.2
Stabler, T.V.3
Renner, J.M.4
Jordan, J.M.5
Kraus, V.B.6
-
13
-
-
78650676944
-
Benefit of massive loss on symptoms, systematic inflammation and cartilage turnover in obese patients with knee osteoarthritis
-
Richette P., Poitou C., Garnero P., Vicaut E., Bouillot J.L., Lacorte J.M., et al. Benefit of massive loss on symptoms, systematic inflammation and cartilage turnover in obese patients with knee osteoarthritis. Ann Rheum Dis 2011, 70:139-144.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 139-144
-
-
Richette, P.1
Poitou, C.2
Garnero, P.3
Vicaut, E.4
Bouillot, J.L.5
Lacorte, J.M.6
-
14
-
-
79952137696
-
Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation
-
Denoble A., Huffman K., Stabler T., Kelley S.J., Hershfield M.S., Mcdaniel G., et al. Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation. Proc Natl Acad Sci USA 2011, 108:2088-2093.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 2088-2093
-
-
Denoble, A.1
Huffman, K.2
Stabler, T.3
Kelley, S.J.4
Hershfield, M.S.5
Mcdaniel, G.6
-
15
-
-
79961119427
-
Biomarkers of incident radiographic knee osteoarthritis
-
Golightly Y.M., Marshall S.W., Kraus V.B., Renner J.B., Villaveces A., Casteel C., et al. Biomarkers of incident radiographic knee osteoarthritis. Arthritis Rheum 2011, 63:2276-2283.
-
(2011)
Arthritis Rheum
, vol.63
, pp. 2276-2283
-
-
Golightly, Y.M.1
Marshall, S.W.2
Kraus, V.B.3
Renner, J.B.4
Villaveces, A.5
Casteel, C.6
-
16
-
-
79957640007
-
Clinical, radiographic, molecular and MRI-based predictors of cartilage loss in knee osteoarthritis
-
Eckstein F., Hellio Le Graverand M.P., Charles H.C., Hunter D.J., Kraus V.B., Sunyer T., et al. Clinical, radiographic, molecular and MRI-based predictors of cartilage loss in knee osteoarthritis. Ann Rheum Dis 2011, 70:1223-1230.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 1223-1230
-
-
Eckstein, F.1
Hellio Le Graverand, M.P.2
Charles, H.C.3
Hunter, D.J.4
Kraus, V.B.5
Sunyer, T.6
-
17
-
-
77957278374
-
Relationship of serum markers of cartilage metabolism to imaging and clinical outcome measures of knee joint structure
-
Berry P.A., Maclewicz R.A., Wluka A.E., Downey-Jones M.D., Forbes A., Hellawell C.J., et al. Relationship of serum markers of cartilage metabolism to imaging and clinical outcome measures of knee joint structure. Ann Rheum Dis 2010, 69:1816-1822.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 1816-1822
-
-
Berry, P.A.1
Maclewicz, R.A.2
Wluka, A.E.3
Downey-Jones, M.D.4
Forbes, A.5
Hellawell, C.J.6
-
18
-
-
78649373401
-
Decrease in serum level of matrix metalloproteinases is predictive of the disease-modifying effect of osteoarthritis drugs assessed by quantitative MRI in patients with knee osteoarthritis
-
Pelletier J.P., Raynauld J.P., Caron J., Mineau F., Abram F., Dorais M., et al. Decrease in serum level of matrix metalloproteinases is predictive of the disease-modifying effect of osteoarthritis drugs assessed by quantitative MRI in patients with knee osteoarthritis. Ann Rheum Dis 2010, 69:2095-2101.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 2095-2101
-
-
Pelletier, J.P.1
Raynauld, J.P.2
Caron, J.3
Mineau, F.4
Abram, F.5
Dorais, M.6
|